Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ian J Jacobs

Showing results (41-50 of 83) with videos related to

Pageof 9
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 17, 2008
Predicting clinical outcome in patients diagnosed with synchronous ovarian and endometrial cancerSusan J Ramus, Karim Elmasry, Zhiyuan Luo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 2005
Prospective study using the risk of ovarian cancer algorithm to screen for ovarian cancerUsha Menon, Steven J Skates, Sara Lewis, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 20, 2005
Diagnostic performance of nanoparticle-enhanced magnetic resonance imaging in the diagnosis of lymph node metastases in patients with endometrial and cervical cancerAndrea G Rockall, Syed A Sohaib, Mukesh G Harisinghani, et al.
Genome Medicine|July 29, 2014
A BRCA1-mutation associated DNA methylation signature in blood cells predicts sporadic breast cancer incidence and survivalShahzia Anjum, Evangelia-Ourania Fourkala, Michal Zikan, et al.
Plos Genetics|February 21, 2012
The dynamics and prognostic potential of DNA methylation changes at stem cell gene loci in women's cancerJoanna Zhuang, Allison Jones, Shih-Han Lee, et al.
Health Technology Assessment (Winchester, England)|May 15, 2023
Mortality impact, risks, and benefits of general population screening for ovarian cancer: the UKCTOCS randomised controlled trialUsha Menon, Aleksandra Gentry-Maharaj, Matthew Burnell, et al.
Journal of Clinical Epidemiology|November 16, 2010
Recruitment of newly diagnosed ovarian cancer patients proved challenging in a multicentre biobanking studyNyaladzi Balogun, Aleksandra Gentry-Maharaj, Eva L Wozniak, et al.
Health Technology Assessment (Winchester, England)|October 16, 2023
Insights from UKCTOCS for design, conduct and analyses of large randomised controlled trialsUsha Menon, Aleksandra Gentry-Maharaj, Matthew Burnell, et al.
The Journal of Pathology|December 4, 2003
Expression of vascular endothelial growth factor (VEGF)-C and VEGF-D, and their receptor VEGFR-3, during different stages of cervical carcinogenesisPhilippe O Van Trappen, Dawn Steele, David G Lowe, et al.
Trials|March 2, 2021
UKCTOCS update: applying insights of delayed effects in cancer screening trials to the long-term follow-up mortality analysisMatthew Burnell, Aleksandra Gentry-Maharaj, Steven J Skates, et al.
Pageof 9

Showing results (41-50 of 83) with videos related to

Sort By:
Pageof 9
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 17, 2008
Predicting clinical outcome in patients diagnosed with synchronous ovarian and endometrial cancerSusan J Ramus, Karim Elmasry, Zhiyuan Luo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 2005
Prospective study using the risk of ovarian cancer algorithm to screen for ovarian cancerUsha Menon, Steven J Skates, Sara Lewis, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 20, 2005
Diagnostic performance of nanoparticle-enhanced magnetic resonance imaging in the diagnosis of lymph node metastases in patients with endometrial and cervical cancerAndrea G Rockall, Syed A Sohaib, Mukesh G Harisinghani, et al.
Genome Medicine|July 29, 2014
A BRCA1-mutation associated DNA methylation signature in blood cells predicts sporadic breast cancer incidence and survivalShahzia Anjum, Evangelia-Ourania Fourkala, Michal Zikan, et al.
Plos Genetics|February 21, 2012
The dynamics and prognostic potential of DNA methylation changes at stem cell gene loci in women's cancerJoanna Zhuang, Allison Jones, Shih-Han Lee, et al.
Health Technology Assessment (Winchester, England)|May 15, 2023
Mortality impact, risks, and benefits of general population screening for ovarian cancer: the UKCTOCS randomised controlled trialUsha Menon, Aleksandra Gentry-Maharaj, Matthew Burnell, et al.
Journal of Clinical Epidemiology|November 16, 2010
Recruitment of newly diagnosed ovarian cancer patients proved challenging in a multicentre biobanking studyNyaladzi Balogun, Aleksandra Gentry-Maharaj, Eva L Wozniak, et al.
Health Technology Assessment (Winchester, England)|October 16, 2023
Insights from UKCTOCS for design, conduct and analyses of large randomised controlled trialsUsha Menon, Aleksandra Gentry-Maharaj, Matthew Burnell, et al.
The Journal of Pathology|December 4, 2003
Expression of vascular endothelial growth factor (VEGF)-C and VEGF-D, and their receptor VEGFR-3, during different stages of cervical carcinogenesisPhilippe O Van Trappen, Dawn Steele, David G Lowe, et al.
Trials|March 2, 2021
UKCTOCS update: applying insights of delayed effects in cancer screening trials to the long-term follow-up mortality analysisMatthew Burnell, Aleksandra Gentry-Maharaj, Steven J Skates, et al.
Pageof 9